• New! Two abstracts have been accepted for the 32nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2022) that is taking place in Lisbon, Portugal on 23 – 26 April 2022:
    • ANTI-SUPERBUGS PCP. A cross-border joint action to improve healthcare-associated infections’ prevention and control systems has been designated as a one-hour oral presentation in the Interventions to prevent HAIs: best learning experiences session of the congress that is scheduled for 26 April;
    • Testing innovative technologies for monitoring multidrug resistant pathogens in clinical settings: Challenges and opportunities of the ANTISUPERBUGS has been designated for poster presentation in the Hospital epidemiology, transmission, surveillance & screening (incl. environment) session of the congress.

    More information: https://www.eccmid.org/

  • Developing Non-Invasive Innovative Technologies to Monitor And Detect Multidrug Resistant Pathogens In Clinical Settings: ANTI-SUPERBUGS Pre-Commercial Procurement Project has been presented as oral presentation in the e-Poster session of the 49th National Congress of the AMCLI Association (Italian Association of Clinical Microbiologists). The congress has taken place in Rimini, Italy from 26th February to 1st March 2022.

    More information: http://www.congresso.amcli.com/
  • Anti-SUPERBugs: A Challenge Brief in a Nutshell. Lecture by Gonçalo Rodrigues

    Content not available.
    Please allow cookies by clicking Accept on the banner
  • HEALTHIO Meeting – 4th May  2017


Anti-SUPERBugs Public Project Deliverable available

  • D2.1 : Business case(s) and prioritized list of common uncovered innovation needs

There are multiple methods to identify and assess needs, but we consider fundamental to base the methodology on the premise that those who are best-placed to see the problems of, or the inefficiencies with, a process or a service are those who work within the system delivering it on daily basis. At the same time, we know that the civil servants involved to deliver the service are typically too busy to consciously consider how the service could be transformed or could benefit from innovation, but they are skilled and perfectly prepared to do it. Here is necessary to make time to take them out of their usual working environment to participate to a brainstorming session.

  • D2.2 : Needs elicitation through questionnaires and WIBGIs events with end-users

With the identification of a list of desired innovative solutions, which have to be validated in comparative terms and put in order of priority, on the basis of their expected costs-benefits, impacts and trends. The Business Case objectives is to validate and rank-order the perceived needs and to address the subsequent technological scanning activities.

  • D2.3: Challenge brief and description of uncovered functionalities

The challenge and procurement must be described in detail to ensure, when published, a full understanding and comparability of the competing solutions proposed by the market in view of potential conversion into permanent services.

  • D3.1: Comprehensive study of the state of the art techniques & technologies, including patent search results

The analysis of the state of the art at worldwide level, key activity in order to understand what technologies are currently available and used and what R&D projects are being developed in the area of healthcare associated infections prevention.

If you are interested in the Anti-SUPERBugs public deliverable documents, please fill in the form available here with your contact information. Your email address will be used only for dissemination activities about the ASB Project.